MYOMO INC(NYSEARCA:MYO) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to MYO. MYO was compared to 190 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for MYO as it has an excellent financial health rating, but there are worries on the profitability. MYO shows excellent growth, but is valued quite expensive already.

Quickly go to:

1. Profitability

1.1 Basic Checks

MYO had negative earnings in the past year.

In the past year MYO has reported a negative cash flow from operations.

MYO had negative earnings in each of the past 5 years.

MYO had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

MYO has a worse Return On Assets (-57.50%) than 71.81% of its industry peers.

MYO has a Return On Equity of -93.26%. This is in the lower half of the industry: MYO underperforms 62.23% of its industry peers.

		Industry Rank	Sector Rank
ROA	-57.5%
ROE	-93.26%
ROIC	N/A

ROA(3y)-72.06%

ROA(5y)-94.76%

ROE(3y)-110.23%

ROE(5y)-213.46%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MYO has a better Gross Margin (70.03%) than 81.91% of its industry peers.

MYO's Gross Margin has been stable in the last couple of years.

MYO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	70.03%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.4%

GM growth 5Y-0.49%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MYO does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for MYO has been increased compared to 1 year ago.

MYO has more shares outstanding than it did 5 years ago.

MYO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 13.03 indicates that MYO is not in any danger for bankruptcy at the moment.

With an excellent Altman-Z score value of 13.03, MYO belongs to the best of the industry, outperforming 90.96% of the companies in the same industry.

There is no outstanding debt for MYO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	13.03

ROIC/WACCN/A

WACC9.19%

2.3 Liquidity

A Current Ratio of 2.49 indicates that MYO has no problem at all paying its short term obligations.

Looking at the Current ratio, with a value of 2.49, MYO is in line with its industry, outperforming 44.15% of the companies in the same industry.

MYO has a Quick Ratio of 2.16. This indicates that MYO is financially healthy and has no problem in meeting its short term obligations.

The Quick ratio of MYO (2.16) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	2.49
Quick Ratio	2.16

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 54.00% over the past year.

Looking at the last year, MYO shows a very strong growth in Revenue. The Revenue has grown by 36.23%.

Measured over the past years, MYO shows a very strong growth in Revenue. The Revenue has been growing by 51.09% on average per year.

EPS 1Y (TTM)54%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%50%

Revenue 1Y (TTM)36.23%

Revenue growth 3Y36.39%

Revenue growth 5Y51.09%

Sales Q2Q%83.09%

3.2 Future

The Earnings Per Share is expected to grow by 28.32% on average over the next years. This is a very strong growth

MYO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.11% yearly.

EPS Next Y37.96%

EPS Next 2Y33.01%

EPS Next 3Y35.81%

EPS Next 5Y28.32%

Revenue Next Year56.52%

Revenue Next 2Y48.34%

Revenue Next 3Y37.29%

Revenue Next 5Y30.12%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYO. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MYO. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

MYO's earnings are expected to grow with 35.81% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y33.01%

EPS Next 3Y35.81%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for MYO!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MYOMO INC

NYSEARCA:MYO (2/20/2025, 1:24:37 PM)

5.91

-0.13 (-2.15%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)11-06 2024-11-06/amc

Earnings (Next)03-06 2025-03-06/amc

Inst Owners43.5%

Inst Owner Change36.95%

Ins Owners6.24%

Ins Owner Change-0.25%

Market Cap199.11M

Analysts80

Price Target7.82 (32.32%)

Short Float %2.43%

Short Ratio1.86

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)43.14%

Min EPS beat(2)28.72%

Max EPS beat(2)57.57%

EPS beat(4)2

Avg EPS beat(4)15.38%

Min EPS beat(4)-20.53%

Max EPS beat(4)57.57%

EPS beat(8)5

Avg EPS beat(8)15.53%

EPS beat(12)8

Avg EPS beat(12)12.9%

EPS beat(16)12

Avg EPS beat(16)15.11%

Revenue beat(2)2

Avg Revenue beat(2)7.36%

Min Revenue beat(2)2.31%

Max Revenue beat(2)12.41%

Revenue beat(4)2

Avg Revenue beat(4)1.11%

Min Revenue beat(4)-8.67%

Max Revenue beat(4)12.41%

Revenue beat(8)5

Avg Revenue beat(8)3.77%

Revenue beat(12)8

Avg Revenue beat(12)8.7%

Revenue beat(16)12

Avg Revenue beat(16)15.23%

PT rev (1m)0%

PT rev (3m)20.6%

EPS NQ rev (1m)-14.29%

EPS NQ rev (3m)N/A

EPS NY rev (1m)8.67%

EPS NY rev (3m)8.67%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)3.73%

Revenue NY rev (1m)0%

Revenue NY rev (3m)3.8%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	7.89
P/FCF	N/A
P/OCF	N/A
P/B	22.15
P/tB	22.15
EV/EBITDA	N/A

EPS(TTM)-0.23

EYN/A

EPS(NY)-0.06

Fwd EYN/A

FCF(TTM)-0.28

FCFYN/A

OCF(TTM)-0.27

OCFYN/A

SpS0.75

BVpS0.27

TBVpS0.27

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-57.5%
ROE	-93.26%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	70.03%
FCFM	N/A

ROA(3y)-72.06%

ROA(5y)-94.76%

ROE(3y)-110.23%

ROE(5y)-213.46%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.4%

GM growth 5Y-0.49%

F-Score3

Asset Turnover1.73

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	373.7%
Cap/Sales	2.11%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.49
Quick Ratio	2.16
Altman-Z	13.03

F-Score3

WACC9.19%

ROIC/WACCN/A

Cap/Depr(3y)123.44%

Cap/Depr(5y)93.68%

Cap/Sales(3y)1.28%

Cap/Sales(5y)1.16%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)54%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%50%

EPS Next Y37.96%

EPS Next 2Y33.01%

EPS Next 3Y35.81%

EPS Next 5Y28.32%

Revenue 1Y (TTM)36.23%

Revenue growth 3Y36.39%

Revenue growth 5Y51.09%

Sales Q2Q%83.09%

Revenue Next Year56.52%

Revenue Next 2Y48.34%

Revenue Next 3Y37.29%

Revenue Next 5Y30.12%

EBIT growth 1Y-4.57%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year20.73%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y1.92%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y6.11%

OCF growth 3YN/A

OCF growth 5YN/A

MYOMO INC (MYO) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens